This inventor holds 2 USPTO granted patents. Top assignee: Basf Aktiengesellschaft. Active years: 1998-1999.
Company Filing History:
Years Active: 1998-1999
Title: The Innovative Contributions of Daniel Belik
Introduction
Daniel Belik is a notable inventor based in Frankfurt, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of antitumor agents. With a total of 2 patents to his name, Belik's work is recognized for its potential impact on cancer treatment.
Latest Patents
Belik's latest patents include "Tetrapeptides as Antitumor Agents" and "Pentapeptides as Antitumor Agents." These inventions provide innovative anti-tumor peptides that could play a crucial role in cancer therapy. The formulations outlined in these patents demonstrate his commitment to advancing medical science and improving patient outcomes.
Career Highlights
Belik is currently employed at BASF Aktiengesellschaft, a leading global chemical company. His role at BASF allows him to collaborate with other experts in the field and contribute to groundbreaking research. His work is characterized by a focus on practical applications of his inventions, aiming to bring new solutions to market.
Collaborations
Throughout his career, Belik has worked alongside talented colleagues such as Teresa Barlozzari and Andreas Haupt. These collaborations have fostered a creative environment that encourages innovation and the sharing of ideas.
Conclusion
Daniel Belik's contributions to the field of biotechnology, particularly in the development of antitumor agents, highlight his role as a significant inventor. His patents reflect a dedication to improving cancer treatment and advancing medical research.